12 results
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Cytokine Activation Syndrome ... Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... take any other medications ... been shown non-inferior ... semaglutide #Diabetes #Pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
other factors (e.g ... ., concomitant medications ... intraocular levels of drug ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
on MRA/CTA • Anterior ... Diagnosis: • Infection ... Electrolyte abnormality, Medication ... /Drug toxicity, ... #diagnosis #management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
weekly + INH 15 mg/kg ... dosing recommendations ... Guidelines for dosing ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
Stewardship: → What syndrome ... → What drug? ... if frequency of medication ... #antibiotics #management ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Prophylaxis): Indications ... to Table 5 for dosing ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Complex Regional Pain Syndrome (CRPS) - Treatment
Non-Pharmacologic:
 • Education
 • Physical & occupational therapy
 • Psychology
Regional Pain Syndrome ... Treatment Non-Pharmacologic ... behavioral therapy) Medications ... Trigger point injections ... #Treatment #Management
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
fibromyalgia) • Infections ... pancreatitis, protein-losing ... extremities Drug ... • Antihistone: Drug ... activation and/or medications
Tuberculosis Dosing Recommendations for Adult Patients With Reduced Renal Function (CKD)
Isoniazid 300 mg once daily, or
Tuberculosis Dosing ... #Tuberculosis #Dosing ... #CKD #pharmacology ... #medications #management ... #Drugs